{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:59:41Z","timestamp":1790506781489,"version":"4.1.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.autrev.2018.04.008","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T02:59:27Z","timestamp":1533956367000},"page":"1002-1010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus"],"prefix":"10.1016","volume":"17","author":[{"given":"Kyle T.","family":"Amber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Valdebran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Grando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.04.008_bb0005","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0010","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.04.008_bb0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Wieczorek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0025","first-page":"492","article-title":"Clinical analysis of Unicentric Castleman's disease with paraneoplastic pemphigus and bronchiolitis obliterans","volume":"39","author":"Zhen","year":"2017","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.autrev.2018.04.008_bb0030","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/bjh.13378","article-title":"Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single Centre: paraneoplastic pemphigus is an unfavourable prognostic factor","volume":"169","author":"Dong","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2007.08361.x","article-title":"Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus","volume":"158","author":"Liu","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.04.008_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000357109","article-title":"Paraneoplastic pemphigus occurs most commonly in indolent B cell lymphoma","volume":"132","author":"Morikawa","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0050","first-page":"486","article-title":"Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus","volume":"122","author":"Li","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2018.04.008_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12032-009-9304-y","article-title":"A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease","volume":"27","author":"Fang","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0190-9622(99)70111-8","article-title":"Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans","volume":"41","author":"Chorzelski","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","article-title":"Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations","volume":"40","author":"Kaplan","year":"2004","journal-title":"Oral Oncol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/idoj.IDOJ_17_17","article-title":"Paraneoplastic pemphigus with underlying retroperitoneal inflammatory Myofibroblastic tumor: a case report and review of the literature","volume":"8","author":"Shahidi-Dadras","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.autrev.2018.04.008_bb0075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/ijd.12603","article-title":"Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients","volume":"54","author":"Lehman","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5021\/ad.2017.29.2.219","article-title":"Paraneoplastic pemphigus associated with a malignant Thymoma: a case of persistent and refractory oral ulcerations following Thymectomy","volume":"29","author":"Lim","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4143\/crt.2013.45.1.70","article-title":"A case report of paraneoplastic pemphigus associated with esophageal squamous cell carcinoma","volume":"45","author":"Cho","year":"2013","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.autrev.2018.04.008_bb0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4103\/0366-6999.183422","article-title":"A case report on paraneoplastic pemphigus associated colonic carcinoma","volume":"129","author":"Wang","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2018.04.008_bb0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2141.2010.08075.x","article-title":"Paraneoplastic pemphigus due to CD8-positive cytotoxic T-cell lymphoma","volume":"149","author":"Gill","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2340\/00015555-2169","article-title":"Paraneoplastic autoimmune multi-organ syndrome: association with retroperitoneal Kaposi's sarcoma","volume":"96","author":"Ghigliotti","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bjd.13334","article-title":"Paraneoplastic pemphigus associated with metastatic lymphoepithelioma-like carcinoma originating from the thyroid gland","volume":"172","author":"Hong","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0110","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/000155502320624177","article-title":"A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy","volume":"82","author":"Verrini","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-4632.2009.03995.x","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome","volume":"48","author":"Sehgal","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.04.008_bb0135","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1346-8138.13329","article-title":"Erosive oral lichen planus as a sign of paraneoplastic pemphigus","volume":"43","author":"Wang","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/cup.12666","article-title":"Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy","volume":"43","author":"Schaberg","year":"2016","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2018.04.008_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0150","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/PAS.0000000000000900","article-title":"Cutaneous eruptions in patients receiving immune checkpoint blockade: Clinicopathologic analysis of the nonlichenoid histologic pattern","volume":"41","author":"Kaunitz","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ijd.13540","article-title":"Histopathological aspects of cutaneous erythematous-papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma","volume":"56","author":"Perret","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/DAD.0000000000000688","article-title":"Lichenoid dermatologic toxicity from immune checkpoint blockade therapy: a detailed examination of the Clinicopathologic features","volume":"39","author":"Tetzlaff","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cup.12858","article-title":"Diverse types of dermatologic toxicities from immune checkpoint blockade therapy","volume":"44","author":"Curry","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.autrev.2018.04.008_bb0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ijd.13984","article-title":"A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors","volume":"57","author":"Lopez","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0175","first-page":"196","article-title":"Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma","volume":"16","author":"Amber","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.autrev.2018.04.008_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2017-01-761346","article-title":"PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD","volume":"130","author":"Haverkos","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.04.008_bb0185","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00520-017-3629-4","article-title":"Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors","volume":"25","author":"Vigarios","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.autrev.2018.04.008_bb0190","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1753465816636557","article-title":"Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis","volume":"10","author":"Abdel-Rahman","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.autrev.2018.04.008_bb0195","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14282","article-title":"Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus","volume":"174","author":"Poot","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0200","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjd.12479","article-title":"Laboratory diagnosis of paraneoplastic pemphigus","volume":"169","author":"Poot","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0205","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0190-9622(93)70095-B","article-title":"Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus","volume":"28","author":"Liu","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0923-1811(98)00005-X","article-title":"Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus","volume":"17","author":"Hashimoto","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2018.04.008_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2018.04.008_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAT.0000000000000196","article-title":"Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus","volume":"47","author":"Kelly","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.autrev.2018.04.008_bb0225","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bjd.15389","article-title":"Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope-spreading phenomena","volume":"176","author":"Okahashi","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0046-8177(89)90272-4","article-title":"Basement membrane components in lymphoid follicles: immunohistochemical demonstration and relationship to the follicular dendritic cell network","volume":"20","author":"Gloghini","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0235","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1365-4632.2007.03267.x","article-title":"Immunoglobulin variable region gene analysis to the autoantibody-secreting B cells from tumors in association with paraneoplastic autoimmune multiorgan syndrome","volume":"46","author":"Wang","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0240","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(04)15539-6","article-title":"Castleman's tumours and production of autoantibody in paraneoplastic pemphigus","volume":"363","author":"Wang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.04.008_bb0245","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(03)02160-1","article-title":"Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus","volume":"49","author":"Futei","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0250","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/jid.2011.448","article-title":"Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules","volume":"132","author":"Ohyama","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0255","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/jid.2012.1","article-title":"Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera","volume":"132","author":"Brandt","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1067\/mjd.2001.112222","article-title":"Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus","volume":"44","author":"Ohyama","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0265","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2133.2001.04095.x","article-title":"Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies","volume":"144","author":"Inaoki","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.04.008_bb0275","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M508017200","article-title":"A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis","volume":"281","author":"Galliano","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2018.04.008_bb0280","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0285","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0290","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2133.1999.03123.x","article-title":"Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus","volume":"141","author":"Reich","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0295","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1172\/JCI57379","article-title":"Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice","volume":"121","author":"Takahashi","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2018.04.008_bb0300","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2018.02.044","article-title":"TH1\/TH17 cell recognition of desmoglein 3 and bullous pemphigoid antigen 180 in patients with lichen planus","volume":"142","author":"Schmidt","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaad.2006.06.007","article-title":"Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies","volume":"56","author":"Cummins","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0310","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/0378-6323.136898","article-title":"Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) with unusual manifestations and without detectable autoantibodies","volume":"80","author":"Sanz-Bueno","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0315","series-title":"Ocular Onset of Paraneoplastic Pemphigus Presenting as Hyperemic Conjunctivitis and Massive Bilateral Eyelid Ulceration: A Case Report and Literature Review","first-page":"265","volume":"26","author":"Piscopo","year":"2018"},{"key":"10.1016\/j.autrev.2018.04.008_bb0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12886-016-0280-7","article-title":"Recurrent corneal melting in the paraneoplastic pemphigus associated with Castleman's disease","volume":"16","author":"Gong","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0325","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","article-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab","volume":"38","author":"Anan","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2008.1306","article-title":"Paraneoplastic pemphigus: An uncommon cause of chronic cicatrising conjunctivitis","volume":"2009","author":"Tam","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2018.04.008_bb0335","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9394(14)74494-0","article-title":"Conjunctival involvement in paraneoplastic pemphigus","volume":"114","author":"Meyers","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0340","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ophtha.2009.09.006","article-title":"Paraneoplastic conjunctival cicatrization: two different pathogenic types","volume":"117","author":"Ahuero","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2018.04.008_bb0345","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000051622","article-title":"Bilateral corneal melting in a patient with paraneoplastic pemphigus","volume":"202","author":"Beele","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2018.04.008_bb0350","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0161-6420(92)32030-5","article-title":"Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma","volume":"99","author":"Lam","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.autrev.2018.04.008_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","article-title":"Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome","volume":"14","author":"Maldonado","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.autrev.2018.04.008_bb0360","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-015-9732-8","article-title":"A systematic review of patients with Mucocutaneous and respiratory complications in paraneoplastic autoimmune multiorgan syndrome: Castleman's disease is the predominant malignancy","volume":"193","author":"Lee","year":"2015","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2018.04.008_bb0365","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2133.2003.05659.x","article-title":"Paraneoplastic pemphigus in association with Castleman's disease","volume":"149","author":"Nikolskaia","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1096-9896(199602)178:2<146::AID-PATH431>3.0.CO;2-N","article-title":"Expression of markers of differentiation in normal bronchial epithelium and bronchial dysplasia","volume":"178","author":"Pendleton","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0375","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02889883","article-title":"Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines","volume":"45","author":"Blobel","year":"1984","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0380","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1432-0436.1989.tb00821.x","article-title":"Expression of intermediate filament proteins in fetal and adult human lung tissues","volume":"40","author":"Broers","year":"1989","journal-title":"Differentiation"},{"key":"10.1016\/j.autrev.2018.04.008_bb0385","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM200307243490421","article-title":"CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease","volume":"349","author":"Hoffman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.04.008_bb0390","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1684\/ejd.2011.1598","article-title":"Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus","volume":"22","author":"Iida","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0395","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.1992.03480110076037","article-title":"Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation","volume":"267","author":"Fullerton","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2018.04.008_bb0400","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjd.14234","article-title":"Reply to: clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"174","author":"Amber","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.1203536","article-title":"Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus","volume":"191","author":"Hata","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0410","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0415","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI115781","article-title":"Human autoantibodies against desmoplakins in paraneoplastic pemphigus","volume":"89","author":"Oursler","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.04.008_bb0420","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.leukres.2008.07.031","article-title":"Nonhematological autoimmunity (glomerulosclerosis, paraneoplastic pemphigus and paraneoplastic neurological syndrome) in a patient with chronic lymphocytic leukemia: diagnosis, prognosis and management","volume":"33","author":"Qian","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.autrev.2018.04.008_bb0425","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00432-010-0874-z","article-title":"Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases","volume":"137","author":"Zhang","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0430","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2230.2011.04081.x","article-title":"Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection","volume":"36","author":"Jing","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0435","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/08916930600972099","article-title":"Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis","volume":"39","author":"Billet","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2018.04.008_bb0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-4362.2001.01169.x","article-title":"Paraneoplastic pemphigus","volume":"40","author":"Kimyai-Asadi","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0445","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.det.2011.06.016","article-title":"Current management strategies in paraneoplastic pemphigus","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.autrev.2018.04.008_bb0450","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1087-0024.2004.00826.x","article-title":"New approaches to the treatment of pemphigus","volume":"9","author":"Grando","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"16","key":"10.1016\/j.autrev.2018.04.008_bb0455","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2169\/internalmedicine.0578-17","article-title":"Paraneoplastic pemphigus associated with B-cell chronic lymphocytic leukemia treated with Ibrutinib and rituximab","volume":"57","author":"Ito","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2018.04.008_bb0460","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1111\/ajd.12615","article-title":"Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia","volume":"58","author":"Lee","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0465","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.04.008_bb0470","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3960\/jslrt.55.83","article-title":"Rituximab monotherapy and rituximab-containing chemotherapy were effective for paraneoplastic pemphigus accompanying follicular lymphoma, but not for subsequent bronchiolitis obliterans","volume":"55","author":"Hirano","year":"2015","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.autrev.2018.04.008_bb0475","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-4632.2008.03444.x","article-title":"Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab","volume":"47","author":"Meijs","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-3083.2005.01345.x","article-title":"Therapy of paraneoplastic pemphigus with rituximab: a case report and review of literature","volume":"20","author":"Barnadas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0485","first-page":"564","article-title":"Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus","volume":"2","author":"Schadlow","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0490","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0495","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0500","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12185-017-2305-2","article-title":"Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy","volume":"106","author":"Lee","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0505","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00277-017-3008-8","article-title":"Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus","volume":"96","author":"Kikuchi","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0510","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1346-8138.13160","article-title":"Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin","volume":"43","author":"Namba","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0515","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/imj.12576","article-title":"Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy","volume":"44","author":"Hwang","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2018.04.008_bb0520","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ijd.12053","article-title":"Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab","volume":"54","author":"Kanwar","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0525","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/1744666X.4.3.351","article-title":"Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus","volume":"4","author":"Vezzoli","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0530","first-page":"717","article-title":"Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia","volume":"18","author":"Schierl","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0535","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2230.2006.02331.x","article-title":"Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy","volume":"32","author":"Hoque","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0540","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1111\/jdv.14500","article-title":"Paraneoplastic pemphigus seen in four patients with haematological malignancies formerly treated with rituximab","volume":"32","author":"Baykal","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0545","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","article-title":"Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia","volume":"73","author":"Hohwy","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0555","doi-asserted-by":"crossref","first-page":"18012","DOI":"10.1038\/nrdp.2018.12","article-title":"Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes","volume":"4","author":"Amber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2018.04.008_bb0560","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0190-9622(90)70249-H","article-title":"The relationship of pemphigus to neoplasia","volume":"23","author":"Younus","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0565","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa","year":"1995","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2018.04.008_bb0570","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jamadermatol.2017.6334","article-title":"Coexistent solid malignancies in pemphigus: a population-based study","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0575","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/jid.2014.547","article-title":"Malignancies in pemphigus and pemphigoid diseases","volume":"135","author":"Schulze","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0580","doi-asserted-by":"crossref","DOI":"10.1111\/ajd.12764","article-title":"Association between bullous pemphigoid and malignancy: a meta-analysis","author":"Lucariello","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0585","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-alpha-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus","volume":"133","author":"Numata","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0590","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/jid.2014.151","article-title":"Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus","volume":"134","author":"Tsuchisaka","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0595","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0600","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2133.2004.05995.x","article-title":"The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus","volume":"151","author":"Hisamatsu","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0605","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2230.2009.03241.x","article-title":"Autoantibodies against desmocollins in European patients with pemphigus","volume":"34","author":"Muller","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0610","unstructured":"(!!! INVALID CITATION !!!)."},{"key":"10.1016\/j.autrev.2018.04.008_bb0615","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2133.2006.07717.x","article-title":"Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus","volume":"156","author":"Mentink","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0923-1811(03)00072-0","article-title":"No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases","volume":"32","author":"Ota","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2018.04.008_bb0625","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.04.008_bb0630","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1523-1747.2000.00088-2.x","article-title":"Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies","volume":"115","author":"Kazerounian","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0635","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0640","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-008-0901-y","article-title":"Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus","volume":"301","author":"Huang","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2018.04.008_bb0645","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.07.021","article-title":"Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay","volume":"129","author":"Mouquet","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0650","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2133.2010.09845.x","article-title":"Serum plakophilin-3 autoreactivity in paraneoplastic pemphigus","volume":"163","author":"Lambert","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0655","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1523-1747.1999.00498.x","article-title":"Human autoantibodies against HD1\/plectin in paraneoplastic pemphigus","volume":"112","author":"Proby","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0660","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1368-8375(98)00059-1","article-title":"Paraneoplastic pemphigus: a review","volume":"34","author":"Sklavounou","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0665","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/exd.12229","article-title":"Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris","volume":"22","author":"Amber","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0670","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0675","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2018.04.008_bb0680","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.04.008_bb0685","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ICL.0000000000000155","article-title":"Pemphigus: an ophthalmological review","volume":"42","author":"Chirinos-Saldana","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.autrev.2018.04.008_bb0690","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2340\/00015555-2611","article-title":"Mortality and cause of death in patients with pemphigus","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0695","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.04.008_bb0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00281-015-0541-1","article-title":"Immune response in pemphigus and beyond: progresses and emerging concepts","volume":"38","author":"Di Zenzo","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0705","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.1992.01680180085011","article-title":"Histologic features of paraneoplastic pemphigus","volume":"128","author":"Horn","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0710","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1523-1747.ep12389680","article-title":"Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris","volume":"103","author":"Joly","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.04.008_bb0715","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1590\/S1807-59322011001200004","article-title":"Analysis of the reactivity of indirect immunofluorescence in patients with pemphigus foliaceus and pemphigus vulgaris using rat bladder epithelium as a substrate","volume":"66","author":"Ortolan","year":"2011","journal-title":"Clinics (Sao Paulo)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T16:25:08Z","timestamp":1604766308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218301824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1568997218301824"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.04.008","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}